The Increasing Prevalence of Fentanyl: A Urinalysis-Based Study Among Individuals With Opioid Use Disorder in New York City

Overview

Journal Am J Addict

Specialty Psychiatry

Date 2020 Aug 11

PMID 32776640

Citations 21

Authors

Suky Martinez

Jermaine D Jones

Laura Brandt

Aimee N C Campbell

Rebecca Abbott

Sandra D Comer

Affiliations

Soon will be listed here.

Abstract

Background And Objectives: Opioid-related overdose deaths in North America have increased drastically, partially due to the increased prevalence of illicitly manufactured fentanyl. The current study sought to assess the prevalence and intentionality of fentanyl use among individuals with opioid use disorder (OUD).

Methods: For this secondary analysis (study 1) we screened a total of 1118 urine samples from 316 participants with OUD from 2016 to 2019. Fentanyl knowledge and intentionality of use were assessed in a separate OUD sample (study 2; N = 33).

Results: In study 1, 34.6% of all urine samples tested positive for fentanyl. Overall, 149 (47.2%) participants provided more than or equal to one urine sample that tested fentanyl-positive, and 93 (29.4%) provided more than or equal to two fentanyl-positive samples. The number of fentanyl-positive samples, relative to the number of samples tested each year, increased by 330% from year 1 to 3. Study 2 found all participants had pre-existing knowledge that drugs may be adulterated with fentanyl, yet 67% were surprised by their own fentanyl-positive test result.

Discussion And Conclusions: Like previous studies, our data indicate the high prevalence of fentanyl exposure and low perception of fentanyl-related risk among individuals with OUD, respectively, suggesting that opioid overdose harm reduction efforts may need to focus more on drug users' understanding of risks related to fentanyl use and adulteration of drugs.

Scientific Significance: The current studies provide longitudinal data on fentanyl exposure prevalence and risk perception that is uniquely granular by assessing OUD treatment status, and by identifying potential associations between fentanyl exposure with the presence of other drug use and nonfatal overdose. (Am J Addict 2021;30:65-71).

Citing Articles

"They Don't Give You No Note If It's Got Fentanyl": Using Cognitive Interviews to Understand Self-report and Urine Drug Screen Discrepancies.

Watson D, Clark K, Dennis M, Grella C, Hart M Subst Use. 2025; 19:29768357251316220.

PMID: 39896216 PMC: 11783554. DOI: 10.1177/29768357251316220.

Impact of the Coronavirus Disease 2019 Pandemic on Substance Use Disorder Risk Among People Living With Human Immunodeficiency Virus (HIV) Enrolled in HIV Care in the United States: An Interrupted Time Series Analysis.

Jain J, Heise M, Lisha N, Moreira C, Glidden D, Burkholder G Open Forum Infect Dis. 2024; 11(9):ofae491.

PMID: 39252870 PMC: 11382144. DOI: 10.1093/ofid/ofae491.

Evolution of Fentanyl Prescription Patterns and Administration Routes in Primary Care in Salamanca, Spain: A Comprehensive Analysis from 2011 to 2022.

Torres-Bueno C, Sanchez-Barba M, Miron-Canelo J, Gonzalez-Nunez V Healthcare (Basel). 2024; 12(16).

PMID: 39201177 PMC: 11353527. DOI: 10.3390/healthcare12161619.

Strategies used to reduce harms associated with fentanyl exposure among rural people who use drugs: multi-site qualitative findings from the rural opioid initiative.

Walters S, Baker R, Frank D, Fadanelli M, Rudolph A, Zule W Harm Reduct J. 2024; 21(1):154.

PMID: 39182116 PMC: 11344336. DOI: 10.1186/s12954-024-01062-2.

Psychostimulant drug co-ingestion in non-fatal opioid overdose.

Shastry S, Shulman J, Aldy K, Brent J, Wax P, Manini A Drug Alcohol Depend Rep. 2024; 10:100223.

PMID: 38463635 PMC: 10920112. DOI: 10.1016/j.dadr.2024.100223.

References

Arfken C, Suchanek J, Greenwald M . Characterizing fentanyl use in methadone-maintained clients. J Subst Abuse Treat. 2017; 75:17-21. DOI: 10.1016/j.jsat.2017.01.004. View

Kenney S, Anderson B, Conti M, Bailey G, Stein M . Expected and actual fentanyl exposure among persons seeking opioid withdrawal management. J Subst Abuse Treat. 2018; 86:65-69. PMC: 5808984. DOI: 10.1016/j.jsat.2018.01.005. View

Maxwell J . Is Cocaine Coming Back? A Commentary. Subst Use Misuse. 2019; 55(2):345-348. DOI: 10.1080/10826084.2019.1664592. View

McGowan C, Harris M, Platt L, Hope V, Rhodes T . Fentanyl self-testing outside supervised injection settings to prevent opioid overdose: Do we know enough to promote it?. Int J Drug Policy. 2018; 58:31-36. DOI: 10.1016/j.drugpo.2018.04.017. View

Dezman Z, Felemban W, Bontempo L, Wish E . Evidence of fentanyl use is common and frequently missed in a cross-sectional study of emergency department patients in Baltimore, Maryland. Clin Toxicol (Phila). 2019; 58(1):59-61. DOI: 10.1080/15563650.2019.1605078. View

Goldman J, Waye K, Periera K, Krieger M, Yedinak J, Marshall B . Perspectives on rapid fentanyl test strips as a harm reduction practice among young adults who use drugs: a qualitative study. Harm Reduct J. 2019; 16(1):3. PMC: 6325714. DOI: 10.1186/s12954-018-0276-0. View

Ciccarone D, Ondocsin J, Mars S . Heroin uncertainties: Exploring users' perceptions of fentanyl-adulterated and -substituted 'heroin'. Int J Drug Policy. 2017; 46:146-155. PMC: 5577861. DOI: 10.1016/j.drugpo.2017.06.004. View

Cicero T, Ellis M, Kasper Z . Increases in self-reported fentanyl use among a population entering drug treatment: The need for systematic surveillance of illicitly manufactured opioids. Drug Alcohol Depend. 2017; 177:101-103. DOI: 10.1016/j.drugalcdep.2017.04.004. View

Peiper N, Clarke S, Vincent L, Ciccarone D, Kral A, Zibbell J . Fentanyl test strips as an opioid overdose prevention strategy: Findings from a syringe services program in the Southeastern United States. Int J Drug Policy. 2018; 63:122-128. DOI: 10.1016/j.drugpo.2018.08.007. View

10.

Moallef S, Nosova E, Milloy M, DeBeck K, Fairbairn N, Wood E . Knowledge of Fentanyl and Perceived Risk of Overdose Among Persons Who Use Drugs in Vancouver, Canada. Public Health Rep. 2019; 134(4):423-431. PMC: 6598144. DOI: 10.1177/0033354919857084. View

11.

Jones J, Mogali S, Comer S . Polydrug abuse: a review of opioid and benzodiazepine combination use. Drug Alcohol Depend. 2012; 125(1-2):8-18. PMC: 3454351. DOI: 10.1016/j.drugalcdep.2012.07.004. View

12.

Krieger M, Goedel W, Buxton J, Lysyshyn M, Bernstein E, Sherman S . Use of rapid fentanyl test strips among young adults who use drugs. Int J Drug Policy. 2018; 61:52-58. PMC: 6701177. DOI: 10.1016/j.drugpo.2018.09.009. View

13.

Alexander M, Kiang M, Barbieri M . Trends in Black and White Opioid Mortality in the United States, 1979-2015. Epidemiology. 2018; 29(5):707-715. PMC: 6072374. DOI: 10.1097/EDE.0000000000000858. View

14.

Hoots B, Vivolo-Kantor A, Seth P . The rise in non-fatal and fatal overdoses involving stimulants with and without opioids in the United States. Addiction. 2020; 115(5):946-958. PMC: 11301974. DOI: 10.1111/add.14878. View

15.

Busardo F, Pichini S, Pacifici R, Karch S . The Never-Ending Public Health Issue of Adulterants in Abused Drugs. J Anal Toxicol. 2016; 40(7):561-2. DOI: 10.1093/jat/bkw051. View

16.

Karamouzian M, Papamihali K, Graham B, Crabtree A, Mill C, Kuo M . Known fentanyl use among clients of harm reduction sites in British Columbia, Canada. Int J Drug Policy. 2020; 77:102665. DOI: 10.1016/j.drugpo.2020.102665. View

17.

Colon-Berezin C, Nolan M, Blachman-Forshay J, Paone D . Overdose Deaths Involving Fentanyl and Fentanyl Analogs - New York City, 2000-2017. MMWR Morb Mortal Wkly Rep. 2019; 68(2):37-40. PMC: 6336189. DOI: 10.15585/mmwr.mm6802a3. View

18.

ODonnell J, Halpin J, Mattson C, Goldberger B, Gladden R . Deaths Involving Fentanyl, Fentanyl Analogs, and U-47700 - 10 States, July-December 2016. MMWR Morb Mortal Wkly Rep. 2017; 66(43):1197-1202. PMC: 5689219. DOI: 10.15585/mmwr.mm6643e1. View

19.

Fleury M, Djouini A, Hunh C, Tremblay J, Ferland F, Menard J . Remission from substance use disorders: A systematic review and meta-analysis. Drug Alcohol Depend. 2016; 168:293-306. DOI: 10.1016/j.drugalcdep.2016.08.625. View

20.

Jones C, Baldwin G, Compton W . Recent Increases in Cocaine-Related Overdose Deaths and the Role of Opioids. Am J Public Health. 2017; 107(3):430-432. PMC: 5296707. DOI: 10.2105/AJPH.2016.303627. View